3-Mercapto-2-phenylimidazomidazo[1,2-a]pyridines Inhibit the Type II NADH Dehydrogenase in Mycobacterium tuberculosis
RSC Medicinal Chemistry · 2026
DOI: 10.1039/d6md00463f ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2026. Verfasst von Pallavi Saha und 1 weiteren Autor:innen.
Abstract (Originalsprache)
The emergence of drug-resistant Mycobacterium tuberculosis (Mtb) necessitates the development of novel antitubercular agents. In this study, diverse heterocyclic cores (benzoxazole, benzimidazole, pyrimidine, quinoxaline, and imidazo[1,2-a]pyridine) bearing a common thioacetamide...
Zitieren
APA
Saha, P., & Sharma, D. K. (2026). 3-Mercapto-2-phenylimidazomidazo[1,2-a]pyridines Inhibit the Type II NADH Dehydrogenase in Mycobacterium tuberculosis. RSC Medicinal Chemistry. https://doi.org/10.1039/d6md00463f
Vancouver
Saha P, Sharma DK. 3-Mercapto-2-phenylimidazomidazo[1,2-a]pyridines Inhibit the Type II NADH Dehydrogenase in Mycobacterium tuberculosis. RSC Medicinal Chemistry. 2026. doi:10.1039/d6md00463f
BibTeX
@article{Saha2026,
author = {Saha, Pallavi and Sharma, Deepak K},
title = {3-Mercapto-2-phenylimidazomidazo[1,2-a]pyridines Inhibit the Type II NADH Dehydrogenase in Mycobacterium tuberculosis},
journal = {RSC Medicinal Chemistry},
year = {2026},
doi = {10.1039/d6md00463f}
}
EUVIMED